| 0.2052 -0.025 (-10.98%) | 03-02 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.27 |
1-year : | 0.32 |
| Resists | First : | 0.23 |
Second : | 0.27 |
| Pivot price | 0.21  |
|||
| Supports | First : | 0.17 |
Second : | 0.14 |
| MAs | MA(5) : | 0.23 |
MA(20) : | 0.21 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 53.2 |
D(3) : | 67.5 |
| RSI | RSI(14): 43.5 |
|||
| 52-week | High : | 2.23 | Low : | 0.17 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MEHA ] has closed above bottom band by 34.4%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 0.22 - 0.22 | 0.22 - 0.22 |
| Low: | 0.18 - 0.18 | 0.18 - 0.18 |
| Close: | 0.2 - 0.21 | 0.21 - 0.21 |
The company manufactures and distributes nutraceutical supplements in the U.S., covering categories such as pain, energy, prenatal, general health, bone & joint, gastro, immunity, cardiac, detox, brain & memory, sleep, and urinary. It also offers hemp-derived products including capsules, gummies and tinctures.
Fri, 27 Feb 2026
Functional Brands Extends CEO Vesting, Refines Governance Incentives - TipRanks
Thu, 26 Feb 2026
FUNCTIONAL BRANDS INC. (MEHA) Stock, Price, News, Quotes, Forecast and Insights - MSN
Tue, 24 Feb 2026
New telehealth site offers GLP-1 weight care, backed by 23M influencers - Stock Titan
Mon, 15 Dec 2025
Tilray Brands: A Hold On This High-Risk Cannabis Bet Amid Possible Reclassification (TLRY) - Seeking Alpha
Mon, 15 Dec 2025
Functional Brands (NASDAQ: MEHA) posts $0.3M Q3 profit on 57.8% margin - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 5.4 (%) |
| Held by Institutions | 2.5 (%) |
| Shares Short | 30 (K) |
| Shares Short P.Month | 326 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.09 |
| Profit Margin | -5.5 % |
| Operating Margin | -4.7 % |
| Return on Assets (ttm) | -3.3 % |
| Return on Equity (ttm) | -209.4 % |
| Qtrly Rev. Growth | 21.3 % |
| Gross Profit (p.s.) | 0.23 |
| Sales Per Share | 0.41 |
| EBITDA (p.s.) | -0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 2 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | -4.11 |
| PEG Ratio | 0 |
| Price to Book value | 2.27 |
| Price to Sales | 0.49 |
| Price to Cash Flow | 2.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|